Characteristics, Trends, and Outcomes of Heart Donation After Circulatory Death: An Early Analysis of the United

Ahad Firoz1, Imo Ebong2, Martin Cadeiras2

  • 1Department of Internal Medicine, University of California Davis Medical Center, Sacramento, California.

PubMed

Insights

Donation after circulatory death (DCD) offers a safe alternative to increase heart transplantation (HTx) donors. DCD type III and IV heart transplants show comparable outcomes to donation after brain death, supporting expanded DCD use in the US.

Area of Science:

  • Cardiology
  • Transplantation Surgery
  • Organ Donation Research

Background:

  • Heart transplantation (HTx) is severely limited by donor organ scarcity.
  • Donation after circulatory death (DCD) presents a viable alternative to traditional donation after brain death (DBD).
  • Limited data exists on HTx outcomes using DCD donors, especially in the United States.

Purpose of the Study:

  • To evaluate and compare heart transplantation outcomes between donation after brain death (DBD) and donation after circulatory death (DCD) donors.
  • To analyze the safety and efficacy of DCD type III and DCD type IV donors for heart transplantation.
  • To assess the impact of different procurement methods (DPP vs. NRP) for DCD type III donors.

Main Methods:

  • Analysis of the UNOS thoracic database for adult, isolated, first-time orthotopic heart transplant recipients from 2019-2023.
  • Stratification of recipients into three groups: DBD, DCD III, and DCD IV.
  • Subgroup analysis of DCD III donors based on direct procurement and perfusion (DPP) or normothermic regional perfusion (NRP).

Main Results:

  • A cohort of 14,035 HTx recipients was analyzed (DBD 86.5%, DCD III 6.9%, DCD IV 6.5%).
  • DCD III recipients showed a higher incidence of postoperative dialysis; however, all groups had similar rates of stroke, rejection, and mortality.
  • Procurement methods for DCD III donors (DPP vs. NRP) resulted in comparable survival rates.

Conclusions:

  • Both DCD type III and IV heart transplants demonstrate comparable morbidity and survival rates to standard DBD donors.
  • Despite an increased need for postoperative dialysis in DCD III recipients, DCD donation is a safe strategy to expand the donor pool in the US.
  • These findings support the increased utilization of DCD donors to address the critical shortage of organs for heart transplantation.